The FGFR1 gene is amplified in defined subgroups of both NSCLC and SCLC and proved to be a driving oncogene in a substantial subgroup of patients suffering from these cancer types [12, 13]. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.